Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Transitional Cell

Explore clinical trials studying Carcinoma, Transitional Cell. Study availability and eligibility vary by location and protocol.

18 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Transitional Cell trial results

Recruiting

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

NCT07218380

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +16 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • The University of Arizona Cancer Center - North Campus Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Chao Family Comprehensive Cancer Center and Ambulatory Care (CIACC) - Irvine Irvine, California, United States
View all 286 locations
View Trial Details
Recruiting

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

NCT05874921

Conditions
Carcinoma, Carcinoma, Transitional Cell, Disease Attributes, +21 more
Locations
  • Providence St. Johns Health Center Santa Monica, California, United States
  • University of Florida Gainesville, Florida, United States
  • Mount Sinai Medical Center of Florida, Inc. Miami, Florida, United States
  • H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. Tampa, Florida, United States
View all 22 locations
View Trial Details
Completed

A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer

NCT03219333

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +18 more
Locations
  • Alaska Urological Institute Anchorage, Alaska, United States
  • Arizona Oncology Associates, PC - HAL Goodyear, Arizona, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
View all 81 locations
View Trial Details
Completed

A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer

NCT02443324

Conditions
Adenocarcinoma of the Gastroesophageal Junction, Biliary Tract Cancer, Biliary Tract Diseases, +32 more
Locations
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Florida Cancer Specialists and Research Institute St. Petersburg, Florida, United States
  • Tennessee Oncology PLLC Chattanooga, Tennessee, United States
View all 22 locations
View Trial Details
Completed

Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma

NCT03410693

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +2 more
Locations
  • Alaska Clinical Research Center, LLC Anchorage, Alaska, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
View all 161 locations
View Trial Details
Completed

The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study

NCT02793128

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Loma Linda Cancer Center Loma Linda, California, United States
  • University of California Los Angeles, California, United States
  • Providence Medical Institute Santa Monica, California, United States
View all 24 locations
View Trial Details
Completed

Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder

NCT00722553

Conditions
Bladder Cancer, Bladder Neoplasm, Carcinoma, +20 more
Locations
  • The University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Peachtree Hematology/Oncology Consultants Atlanta, Georgia, United States
  • University of Rochester Cancer Center Rochester, New York, United States
  • University of Utah, Huntsman Cancer Institute Salt Lake City, Utah, United States
View all 19 locations
View Trial Details

Related conditions